🇺🇸 FDA
Patent

US 11759459

Treatment of pain by subarachnoid administration of sustained-release liposomal anesthetic compositions

granted A61KA61K31/445A61K31/485

Quick answer

US patent 11759459 (Treatment of pain by subarachnoid administration of sustained-release liposomal anesthetic compositions) held by Pacira Pharmaceuticals, Inc. expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Pacira Pharmaceuticals, Inc.
Grant date
Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/445, A61K31/485, A61K45/06, A61K9/0019